Sigmoidoscopes Market Size, Share, and Industry Analysis, By Type (Flexible and Rigid), By Product Type (Video Sigmoidoscopes and Fiber Sigmoidoscopes), By Usability (Disposable and Reusable), By End-user (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2025-2032

Sigmoidoscopes refer to the endoscopes used to examine the rectum and the lower part of the colon (sigmoid colon). Sigmoidoscopes are commonly used for the diagnosis of conditions such as hemorrhoids, polyps, colon cancer, and inflammatory bowel disease or for the evaluation of symptoms such as rectal bleeding and inflammation.

Sigmoidoscopes are classified as rigid and flexible devices. The rigid sigmoidoscopes are called proctoscopes. Proctoscopes are specifically used to examine the rectum by inserting the device into the rectum to visualize any abnormalities, such as hemorrhoids or inflammation. On the other hand, flexible sigmoidoscopes are used to examine the sigmoid colon, which is the part of the colon located before the rectum. They are longer than proctoscopes and can reach higher into the colon for a more thorough examination. The fiberoptic sigmoidoscope has an eyepiece for the examination, whereas the video sigmoidoscope has a camera at the end, which is connected to the monitor for visualization.

The increasing prevalence of hemorrhoids, colon cancers, and inflammatory bowel diseases, and the growing awareness amongst patients about the importance of early diagnosis & treatment is expected to boost the market growth. Additionally, the market is expected to grow in the forecast period due to the increasing adoption of minimally invasive procedures in the healthcare industry, as these procedures enable faster diagnostic procedures and shorter recovery times. Moreover, technological advancements, such as the development of high-definition imaging systems and flexible devices, have also fueled the growth of the sigmoidoscopes market.

The COVID-19 pandemic disrupted regular checkups and elective diagnostic procedures owing to the global lockdown measures, which negatively impacted the market for sigmoidoscopes. In 2021, the relaxation of the lockdown measures resulted in an increased number of doctor visits and diagnostic procedures, which boosted the market growth. The global sigmoidoscopes market is expected to experience stable growth after the COVID-19-related pandemic recovery. Moreover, the key players’ strategic initiatives, such as the acquisitions and collaborations to increase their market presence, is expected to drive the market in the near future.

Segmentation

Key Insights

The report covers the following key insights:

• Prevalence of Key Diseases By Key Country/Region
• Economic Burden: Colon Cancer, By Key Countries
• Impact of COVID-19 on the Market
• Technological Advancements in Sigmoidoscopes
• Key Industry Developments By Key Players

Analysis by Type

Based on type, the market is classified into flexible and rigid. The flexible segment generated a significant market share. The flexible sigmoidoscope is the more commonly used type, as it allows for a more detailed examination of the sigmoid colon and can also be used to take tissue samples. Furthermore, technological advancements, increasing demand for minimally invasive procedures, and the growing prevalence of colon and rectal diseases are the factors driving the growth of the segment.

• According to WHO, colon cancer is the second leading cause of death associated with cancer. In 2020, over 1.9 million new cases of colorectal cancer were diagnosed across the globe, and more than 930,000 estimated deaths occurred due to colorectal cancer. Such high prevalence and improved awareness regarding the diagnosis is anticipated to increase the adoption of these devices.

The rigid segment is projected to experience considerable growth in the upcoming years due to the superior control and stability offered by rigid sigmoidoscopes during surgical procedures, making them a preferred choice for interventions.

Regional Analysis

To gain extensive insights into the market, Download for Customization

The global market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for a significant market share in 2023. The increase in the incidence of colon cancer, coupled with the rise in awareness of colon cancer screening, is driving the growth of the market in the region. Additionally, the growth in the demand for minimally invasive diagnostic techniques is further expected to drive regional market growth.

• For instance, according to the American Cancer Association, an estimated 153,020 are diagnosed with colorectal cancer in the U.S., and 52,550 people have died from the disease. Such a high prevalence of key diseases is expected to increase awareness regarding diagnosing and using sigmoidoscopes to monitor the colon.

The market in Asia Pacific is expected to witness a higher growth rate in the sigmoidoscopes market due to the growing awareness regarding these diagnostic procedures and the increasing incidence of irritable bowel syndrome. Moreover, surging government initiatives for early disease detection and diagnosis are expected to propel the market growth in the region in the coming years.

• For instance, according to the article published in the Journal of Neurogastroenterology and Motility in April 2023, the prevalence of irritable bowel syndrome in the general population across Japan, China, and South Korea was 14.9%, 5.5%, and 15.6%, respectively. Such high prevalence is expected to increase the adoption of minimally invasive diagnostic tools, including sigmoidoscopes, in the coming years.

Key Players Covered

The report includes key players, such as Olympus Corporation, PENTAX Medical, Baxter, Stapleline Medizintechnik GmbH, Bolton Surgical Ltd, and Parburch Medical Developments Ltd.

Key Industry Developments

• In January 2024, Olympus Corporation acquired Taewoong Medical Co., Ltd, a Korea-based manufacturer of medical devices. Taewoong Medical Co., Ltd has a network in 80 countries. This acquisition enables the company to grow in endoscopic instruments, including sigmoidoscopes.
• In March 2021, Stapleline Medizintechnik GmbH established a subsidiary in Russia to expand its geographical presence in the global sigmoidoscopes market.
• In January 2021, Olympus Corporation acquired Quest Photonic Devices B.V., a Netherlands-based company that specializes in endoscopy. Olympus Corporation acquired this company to expand its endoscopy business, including sigmoidoscopies.